IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity

COVID-19 caused by SARS-CoV-2 has become a global pandemic requiring the development of interventions for the prevention or treatment to curtail mortality and morbidity. No vaccine to boost mucosal immunity or as a therapeutic has yet been developed to SARS-CoV-2. In this study we discover and chara...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:bioRxiv
Main Authors: Ejemel, Monir, Li, Qi, Hou, Shurong, Schiller, Zachary A., Wallace, Aaron L., Amcheslavsky, Alla, Yilmaz, Nese Kurt, Toomey, Jacqueline R., Schneider, Ryan, Close, Brianna J., Chen, Da-Yuan, Conway, Hasahn L., Mohsan, Saeed, Cavacini, Lisa A., Klempner, Mark S., Schiffer, Celia A., Wang, Yang
Format: Artigo
Jezik:Inglês
Izdano: Cold Spring Harbor Laboratory 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7263543/
https://ncbi.nlm.nih.gov/pubmed/32511396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.15.096719
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki